Advancing Diversity, Equity and Inclusion in IBD Award
Presented in partnership with Pfizer Canada
Crohn's and Colitis Canada will not be running this competition in 2026.
This award honours an individual whose clinical work or research advances Crohn’s and Colitis Canada’s Promise by addressing issues related to diversity, equity, and inclusion in inflammatory bowel disease (IBD). Nominations are evaluated by an independent panel of IBD experts, operating at an arm’s length from pharmaceutical partners. The recipient will be granted $20,000 in support of their clinical or research program.
Nomination Criteria
- Open to IBD scientists and researchers in Canada
- Nominations can be submitted by fellow scientists or IBD researchers. Self-nominations are also accepted
Selection Criteria
The recipient will be selected by a Selection Panel comprised of individuals from the following groups, at the discretion of Crohn’s and Colitis Canada, and as appropriate:
- Crohn’s and Colitis Canada Scientific and Medical Advisory Council;
- Canadian Community of Practice of IBD Nurses (CANIBD) members;
- Crohn’s and Colitis Canada IBD patient volunteers;
- Crohn’s and Colitis Canada staff; or
- Other individuals as deemed necessary by Crohn’s and Colitis Canada
How to Apply
- Complete the nomination form
- Attach a letter of support from the nominating applicant, the nominee’s department head, or a colleague
- Attach a CV highlighting the nominee’s accomplishments as it pertains to this award
Past Recipients
2025 Dr. Laura Targownik, Toronto, ON
2024 Dr. Juan-Nicolás Peña-Sánchez, Saskatoon, SK
Contact
For questions about Crohn's and Colitis Canada research grants or awards, please contact:
Research Grants Administrator
Tel: (416) 920-5035 ext. 252
Email: research...crohnsandcolitis...ca
This award is presented in partnership with